Reaction
Circumstance Or Information Capable Of Leading To Device Use Error reporting signals
As of the last recalculation, Circumstance Or Information Capable Of Leading To Device Use Error appears in 2,322 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is SOMATROPIN (PRR 139.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Somatropin | 767 | 139.2 | 140.7 |
| Estradiol Gel 0.1% | 135 | 28.4 | 28.5 |
| Estradiol Transdermal | 135 | 28.4 | 28.4 |
| Albuterol Sulfate | 556 | 21.8 | 21.8 |
| Adalimumab-Adaz | 100 | 17.7 | 17.7 |
| Estradiol | 143 | 15.7 | 15.8 |
| Glatiramer Acetate | 78 | 12.1 | 12.1 |
| Goserelin | 17 | 11.4 | 11.4 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 15 | 8.1 | 8.1 |
| Fluticasone Furoate And Vilanterol Trifenatate | 26 | 6.5 | 6.5 |
| Budesonide And Formoterol Fumarate Dihydrate | 64 | 6.0 | 6.1 |
| Umeclidinium | 6 | 6.0 | 6.0 |
| Etonogestrel | 22 | 4.2 | 4.2 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 7 | 4.0 | 4.0 |
| Fluticasone Propionate And Salmeterol | 17 | 3.7 | 3.7 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 15 | 3.3 | 3.3 |
| Erenumab-Aooe | 8 | 1.3 | 1.3 |